You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
翰宇藥業(300199.SZ)擬出資2000萬元共同設立廣州一村基金
格隆匯 02-20 20:33

格隆匯2月20日丨翰宇藥業(300199.SZ)公佈,為提高企業創新動力,夯實在生物及製藥產業的佈局,公司擬與上海一村股權投資有限公司(以下簡稱“一村投資”)、廣州市新興產業發展基金管理有限公司(以下簡稱“新興基金”)、一村資本有限公司(以下簡稱“一村資本”)等機構合作,投資設立“廣州一村醫療健康產業投資合夥企業(有限合夥)”(以下簡稱“廣州一村基金”或“基金”,具體名稱以工商部門最終核准登記為準)。基金計劃總規模不超過1億元,其中公司擬以自有資金認繳出資不超過2000萬元人民幣,其餘份額由基金管理人一村投資向其他投資人募集。

公司本次擬對外投資合作設立產業發展基金,主要是藉助專業投資機構的資源和平台優勢,重點挖掘創新藥的研究和開發,尤其是多肽創新藥在多種癌症治療領域的應用。廣州一村基金的投資方向主要為醫藥、醫療服務和醫療器械等大健康領域的創新性、高成長性和高附加值項目,本次合作的主要合作方一村資本等有着成熟的大健康領域投資經驗,曾主導完成了對意大利新興腫瘤研發機構Nerviano Medical Sciences Group S.r. l 的收購項目。公司本次擬投資廣州一村基金符合公司的產業規劃,其主要投資方向與公司主營業務有較高契合性,有利於提高公司的產業實力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account